Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

First Human Dose Trial of NNC0195-0092 in Healthy Subjects

This study has been completed.
Information provided by (Responsible Party):
Novo Nordisk A/S Identifier:
First received: January 13, 2012
Last updated: April 11, 2013
Last verified: April 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2013
  Primary Completion Date: March 2013 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):